Vapor Technology Association
Sign In Sign In Sign Out Sign Out
  • Home
  • About
    • About VTA
    • Priorities
    • Governance
    • Industry Marketing Standards
    • FAQ
  • American Impact
  • Membership
  • Action Center
  • News

Vapor Technology Association Vapor Technology Association

Join Today Dashboard
  • Home
  • About
    • About VTA
    • Priorities
    • Governance
    • Industry Marketing Standards
    • FAQ
  • American Impact
  • Membership
  • Action Center
  • News

VTA Litigation Alert – New Mexico

April 13, 2026 by VTA Editors Leave a Comment

State of New Mexico, ex rel, Raul Torrez, Attorney General v. Circle K Stores, Inc., et al. County of Santa Fe, First Judicial District, Case No. D101-CV-2026-00900

Implications for Vapor Industry
VTA is monitoring a newly filed lawsuit brought by the State of New Mexico against several retailers and distributors involved in the sale of flavored disposable vapor products. We recognize that actions of this nature can raise concerns across the industry, and wanted to provide some perspective. The State’s claims rely heavily on generalized public health concerns regarding youth nicotine use and the characteristics of flavored products, rather than identifying specific misrepresentations or unlawful conduct by individual businesses. The State’s theory attempts to treat common product characteristics — such as flavor descriptions, packaging presentation, or consumer demand — as evidence of unfair or deceptive practices.

Key Takeaways for Industry Members

1. The Complaint advances untested legal theories directed at the supply chain
While the Complaint is framed as a public health enforcement action, it relies on expansive and lnovel theories of liability that seek to extend responsibility beyond manufacturers to include participants throughout the lawful supply chain, including retailers and distributor entities whose role is limited to the sale of finished products. The State alleges that participation in ordinary commercial relationships may constitute actionable conduct where products are later alleged to appeal to youth.  Novel and/or expansive theories often face serious scrutiny from courts.  We expect that to be the case here as the State attempts to advance the case.

2. Claims rely heavily on generalized policy concerns rather than individualized misconduct
The Complaint includes wholly incomplete facts and makes misrepresentations regarding youth nicotine use trends and potential health effects of e-cigarettes to support its case. But, the Complaint does not clearly identify specific misrepresentations directed to consumers by the named defendants. This approach reflects an effort to use consumer protection statutes to regulate product characteristics that remain the subject of ongoing federal regulatory review.  This too will invite serious scrutiny from the court.

3. The case seeks to expand traditional interpretations of “unfair practices” law
The State alleges that the marketing and distribution of flavored products may constitute unfair or deceptive conduct even where such products remain widely sold in regulated retail environments subject to age restrictions. Courts have historically required clear statutory authority before extending liability theories that could affect lawful commercial activity.  In Ohio, multiple cases filed by the Attorney General seeking to impose liability under that state’s consumer fraud and/or deceptive practices statute were dismissed based on federal preemption grounds.

4.  Example of Overreach:  Failure to warn claims ring hollow.
The State asserts numerous claims against the distributors and retailers asserting their failure to warn consumers (specifically youth and their parents) about the addictiveness of nicotine.  Of course, every product sold bear the specific federally mandated warning in the specific federally mandated formatting which expressly states that the product contains nicotine and that nicotine is an addictive chemical.  Thus, efforts by the State to impose some higher standard likely will be viewed skeptically.

VTA Perspective

VTA believes it is important for members and industry to understand that:

  • The Complaint does not alter existing federal regulatory requirements governing vapor products.
  • The parties to this case have numerous defenses to challenge the State’s novel and expansive legal theories.
  • The court will closely scrutinize State’s attempts to expand liability theories beyond established precedent, particularly when the alleged facts require serious leaps of logic.
  • Similar cases advancing similar novel theories, including those involving vaping products,  have faced substantial legal challenges and defeats before reaching the merits.
  • To date, the State has not sought to enjoin the sale of these products, but is pursuing this case directly against the named defendants who will mount their defense.

VTA is actively monitoring developments in this case and evaluating potential implications for manufacturers, distributors, and retailers. We are coordinating with legal experts and policy stakeholders to ensure that the interests of responsible industry participants are represented, and will look for opportunities to do so in this case.

We encourage members and industry to remain calm and to continue adhering to applicable age-verification requirements, marketing standards, and regulatory obligations, as compliance remains the strongest safeguard against enforcement risk.

VTA will provide updates as the case progresses.

To stay informed and join our fight, please support our various efforts to fight against government overreach at the federal and state levels. You can do so by joining VTA TODAY!

Filed Under: Government Updates Tagged With: Courts, Enforcement, States

VTA Responds to Gov. Youngkin’s Amendments to SB550/HB1609

April 10, 2024 by VTA Editors

WASHINGTON – April 10, 2024 – The following statement is attributable to Tony Abboud, executive director of the Vapor Technology Association (VTA):

“While VTA is deeply disappointed that the Virginia State Legislature did not consider the science, overwhelming adverse impact on Virginia’s economy, and harm reduction benefits of e-cigarettes when passing SB550/HB1609 , we would like to express our gratitude to Governor Glenn Youngkin’s office for the time and attention they paid to the real danger to Virginia consumers and small businesses of banning all vapor products, an alternative that is currently helping Virginians quit smoking cigarettes.”

“The Governor’s amendment delaying the effective date is wise as it will ensure that Virginia does not precipitously shut down an important industry by rubber stamping a federal regulatory decision-making process which the 5th Circuit Court of Appeals has declared unlawful, the final legality of which the U.S. Supreme Court will be reviewing this year and next. VTA intends to use this time to allow our store owners the opportunity to share with their elected officials just how detrimental this legislation will be to their livelihoods as well as their customers’ health.”

“We applaud Governor Youngkin for issuing these amendments and standing up to Big Tobacco’s continued attempts to boost lagging cigarette sales by immediately shutting down Virginia’s small businesses selling less harmful alternatives to cigarettes.” 

“In light of these developments in Virginia, VTA continues its call for state and federal officials to restore scientific primacy and integrity to the regulations which govern the safe and reliable sales of e-cigarettes to adult consumers.  And VTA applauds the state legislature for passing SB 582/HB 790 – a comprehensive set of reforms that implement the strongest, proven policies that will reduce the appeal of, access to, and use of vapor products by youth – which VTA has been advocating for many years.” 

“VTA looks forward to working with Gov. Youngkin, the General Assembly, and smoking reduction advocates in Virginia to demonstrate why drastic changes in approach are required in the 2025 legislative session.”

Filed Under: Press Releases

Cancer Moonshot & Vaping Ad

March 20, 2024 by VTA Editors Leave a Comment

This ad explains that President Biden has one of the best tools available to achieve his Cancer Moonshot – universal access to flavored e-cigarettes. Smoking is the #1 cause of death and disease in the U.S., but the FDA’s Center for Tobacco Products refuses to authorize less harmful e-cigarettes choosing instead to authorize 900 new cigarettes.

Filed Under: Video

Nanny State Bans on Less Harmful Nicotine

February 6, 2024 by VTA Editors Leave a Comment

VTA’s cable news ad buy targets Sen. Schumer and FDA’s refusal to acknowledge the science on nicotine alternatives that are vastly safer than smoking cigarettes.

Filed Under: Video

NEW POLL: American Public Grossly Misinformed About Benefits of E-Cigarette Use to Smokers & Low Risk of Vaping

November 30, 2023 by VTA Editors

New polling conducted by KAConsulting, LLC, led by U.S. presidential advisor and market analytics expert Kellyanne Conway, reveals misinformation from public health institutions around e-cigarettes creates significant confusion for American public.

WASHINGTON – November 30, 2023 – The Vapor Technology Association (VTA) today
released new polling from pollster Kellyanne Conway, which reveals a significant information
gap in public perception versus reality regarding e-cigarettes being an effective tool for adults in
need of smoking cessation and harm reduction alternatives.

The poll is a national online survey of 1,000 registered U.S. voters, including 35% Republicans;
35% Democrats; 16% independents; and 14% unaffiliated. VTA’s polling sought to better
understand the current state of Americans’ knowledge, perceptions, and opinions on e-cigarette
use, including perceptions of where vaping lies among other risky behaviors, like smoking
cigarettes, drinking alcohol, and smoking marijuana.

The poll confirms what many scientists and academics have lamented for years: The American
people are overwhelmingly misinformed by public health institutions, such as the U.S. Food and
Drug Administration’s Center for Tobacco Products (CTP), on the dramatically lower risks and
significant benefit tradeoffs of vaping nicotine versus smoking cigarettes, which kill nearly half a
million Americans every year.

When provided factual information about e-cigarettes, public perception of vaping skewed from
largely negative towards a demonstrable openness around the potential benefits of e-cigarettes,
particularly for current smokers. Additionally, the poll demonstrates that Americans, despite their
overwhelmingly negative views on e-cigarettes, ranked numerous other behaviors and lifestyle
choices, like drinking alcohol or smoking marijuana, as much riskier.

“The poll that VTA conducted with Kellyanne and her team underscores what we have argued for years: that public health officials and lawmakers must follow the science when it comes to vaping and stop misinforming the public about the benefits and relative risks of e-cigarettes and other non-combustible nicotine products, especially as an effective harm reduction tool for those who currently smoke cigarettes,” said Tony Abboud, executive director of VTA. “This watershed polling demonstrates the clear and present danger of this public health misinformation gap that needs to be addressed.”

“This poll demonstrates the effect of information underload combined with unaddressed confusion about an issue – the result is chaos,” said Kellyanne Conway. “Yet, when Americans are provided accurate information about e-cigarette use, their opinion shifts dramatically. This shows the power of politicized science versus actual science.”

Key findings included in the polling’s results:

  • An overwhelming majority of Americans (84%) have a negative view of vaping nicotine and 78% wrongly believe that vaping nicotine is as or more dangerous than smoking cigarettes.
  • When informed that vaping is more effective than nicotine replacement therapies such a nicotine gums and patches in helping adult smokers quit, 37% of respondents say they are less likely to support a ban.
  • When informed of the United Kingdom’s “Swap to Stop” program of handing out free vaping starter kits to help people stop smoking, 40% of Americans say they would be more likely to support such a program in the U.S.
  • More than half of Americans (53%) say FDA’s rejection of 99% of e-cigarette applications while approving cigarettes over vaping products at a rate of 45 to 1 is unreasonable policy.
  • A majority of Americans (79%) state that banning e-cigarettes would just result in a black market for people to continue buying and selling nicotine vaping products.
  • Half of Americans (49%) say it is unreasonable policy for FDA to use youth vaping as a reason to ban flavored e-cigarettes when FDA also says youth vaping is not an epidemic.
  • More than half (56%) of Americans believe that FDA is making unfair decisions or playing politics about tobacco and vaping and should return to focusing on protecting public health.
  • Only 35% of Americans say FDA should continue on its current path with respect to tobacco and vaping.
  • Vaping nicotine is considered the least dangerous activity (7%) to a person’s life when compared to other activities, like using illegal drugs, not wearing a seatbelt in a car, poor nutrition, and drinking alcohol.

The FDA’s CTP sets tobacco and e-cigarette policy in the U.S. The use of selective science to
justify agenda-driven decisions regarding e-cigarettes or any other less harmful non-
combustible product is ultimately dangerous to public health and confusing for millions of
Americans looking to quit smoking. This new data reveals the extent of this confusion and the
fact the majority of Americans think that FDA is heading in the wrong direction with its e-
cigarette and tobacco policy.

“This polling clearly demonstrates that the FDA’s Center for Tobacco Products has been successful in creating confusion around vaping in the U.S., and when provided the facts, the majority of Americans believe that FDA’s current trajectory of banning virtually all e-cigarettes is the wrong policy which is driven by political and not scientific rationale,” concluded Mr. Abboud.

“VTA looks forward to working with all regulators to correct the record, get the right information about vaping benefits to American consumers, and help reset the FDA’s skewed agenda on less harmful nicotine products based on science and common-sense solutions.”

For more information and a complete copy of the poll, follow the link below.

View Complete Poll Results (PDF)

About VTA

The Vapor Technology Association is the U.S. industry trade association whose members are dedicated to sound science-based regulation and selling innovative high-quality vapor products that provide adult smokers with a better alternative to combustible cigarettes. VTA represents the industry-leading manufacturers of vapor devices, e-liquids, and flavorings, as well as the distributors and retailers, including hardworking American mom-and-pop brick-and-mortar retail store owners.

Also Read VTA’s Executive Director Addresses the 2023 National Youth Tobacco Survey

Filed Under: Press Releases

End Smoking: Give Americans What They Need: Flavored E-Cig

November 23, 2023 by VTA Editors Leave a Comment

VTA first TV ad of 2024 calls on FDA to reverse course and authorize a wide variety of flavored e-cigarettes now.

Filed Under: Video

Warning: The Greatest Threat to Vaping – Disinformation

June 28, 2023 by VTA Editors

During this week’s Next Generation Nicotine Delivery USA 2023 conference, VTA’s Executive Director presented a stark warning to industry leaders about a new orchestrated anti-vaping campaign.

The Next Generation Nicotine Delivery USA 2023 brought together 150+ executives from the industry for two days of insight, discussion and debate in Miami, Florida. VTA’s participation at the event included a keynote presentation and panel discussions led by VTA Executive Director Tony Abboud.

Abboud’s presentation highlighted the misinformation surrounding EVALI that was used to malign nicotine vaping in the past and then revealed a highly-funded ongoing disinformation campaign that is being orchestrated to create a false narrative linking “Chinese-manufactured” flavored disposable nicotine vaping products with fentanyl without substantiation. The presentation also revealed how FDA officials, unlike in 2019, appear to be feeding the false narrative with their public statements.

The presentation drew stark parallels between how certain players used the illicit THC cartridge EVALI crisis of 2019 to attack flavored nicotine vaping, and how the scant cases of illicit THC cartridges being found to contain fentanyl are now being wrongfully amplified and tied to flavored nicotine disposable vaping products. VTA Executive Director Tony Abboud starkly warned that the industry is facing a manufactured crisis – EVALI II – the repurcussions of which will be worse than EVALI. He also warned that the misleading campaign alleging the mass importation of fentanyl-tainted Chinese disposable vapes will threaten the entire nicotine vaping industry, will taint all device types as they are all made in China, will force fear-driven regulatory overreactions that will have nothing to do with the real issue, and will confuse and frighten consumers back to smoking cigarettes.

VTA called on all companies to coalesce, as it did in 2019, around a VTA strategy to answer this false narrative, reminding the audience of the success it had in responding to the ill-considered 2019 flavor ban response to EVALI.

Greatest Threat to Vaping Presentation Deck (PDF)

Filed Under: Events, News

VTA Issues Statement Criticizing FDA Inspection Blitz Announcement

June 25, 2023 by VTA Editors

Vapor Trade Group Warns Against What it Says Is FDA Misinformation That Jeopardizes Harm Reduction Mission

WASHINGTON, June 23, 2023 (Newswire) – Following the FDA’s announcement of what it called a “nationwide retailer inspection blitz” which targeted 189 small business retailers, Vapor Technology Association Executive Director Tony Abboud released the following statement:

“The actions this week by the FDA demonstrate once again that it has no control over the market it is charged with regulating. FDA’s announcement unfairly targets small business owners while offering its tacit support of the biggest companies. FDA currently operates with a de facto policy to remove all non-tobacco flavored vaping products from the market, while it continues to approve combustible tobacco products at an alarming rate. FDA has a responsibility to create a marketplace that allows the most innovative products that adults actually want to use, not arbitrarily pick winners and losers due to pressure from political officials.”

FDA synchronized its “blitz” announcement with not one, but two CDC reports, which misrepresent the real trends in youth vaping. One study cited by FDA was conducted with an agenda driven special interest group and funded by a prominent billionaire. The CDC’s own National Youth Tobacco Survey has shown the dramatic reduction in youth e-cigarette use. Since its peak in 2019, vaping is down 50% amongst high schoolers and 70% amongst middle schoolers, and now sits at 2014 levels.

In fact, Brian King, the Director of the Center for Tobacco Policy (CTP), has stated publicly that CTP no longer considers youth vaping an epidemic. This is welcome news. And given these facts, the reported “rise” in flavored vape sales must necessarily be amongst adults who either desire or need less harmful alternatives to cigarettes.

“FDA has also misused scant data from a second CDC study to sensationalize the risk to small children by claiming a supposed increase in poison control calls – the overwhelming majority of which – 99.8% – had no major effect. This sleight of hand is being used to justify its actions against just one product while at the same time ignoring the data showing two other vaping products owned by cigarette companies were also specifically identified in the study.”

Given the known dangers of smoking, FDA must take a stronger stance on cigarettes than it does on vaping. Instead, the FDA has authorized the sale of 900 new cigarette products, two-thirds of which are owned by the biggest tobacco companies. The FDA can no longer, in good conscience, continue down this path.

34 million adults are addicted to cigarettes – the only product which when used as intended will kill you. By selectively targeting vaping, FDA is working overtime to eliminate effective harm reduction options for adults and ensuring the only option for many will be to continue smoking.”

About VTA

The Vapor Technology Association is the U.S. industry trade association whose members are dedicated to sound science-based regulation and selling innovative high-quality vapor products that provide adult smokers with a better alternative to combustible cigarettes. VTA represents the industry-leading manufacturers of vapor devices, e-liquids, and flavorings, as well as the distributors and retailers, including hardworking American mom-and-pop brick-and-mortar retail store owners.

Filed Under: Press Releases

VTA’s Recommendations to the Reagan-Udall Foundation

December 19, 2022 by VTA Editors

VTA PMTA Recommendations

  1. FDA must implement safeguards at the Center for Tobacco Products (CTP) to ensure that the scientific review process is insulated from external pressures and that CTP scientists are allowed to unapologetically follow the science.
  2. Immediately rescind the July 9, 2021 and August 17, 2021 process memos which resulted in the en masse denial of flavored ENDS products, restore the holistic review process and the primacy of the appropriateness for the protection of public health balancing test.
  3. Build the off-ramp from smoking by accelerating the authorization of ENDS products and using the full scope of CTP’s post-marketing order authority to monitor and control for youth concerns.
  4. Clearly articulate CTP’s use of enforcement discretion to work companies through the PMTA process, particularly for non-tobacco nicotine (i.e., synthetic nicotine) applications.
  5. Communicate with companies to seek additional information or corrections and avoid rejections based on administrative or technical failings and the needless litigation that follows.
  6. Establish defined testing methods for END products which create transparency and certainty.
  7. Eliminate redundant and unnecessary testing to streamline the PMTA process.
  8. Develop and publish a PMTA proposed regulation with a finite checklist of required information that is required for PMTA review.
  9. Equally fund research for identifying how ENDS products can be solutions for smoking, rather than simply identifying problems with ENDS products and youth.

VTA Regulations and Guidance Recommendations

  1. CTP should implement a Comprehensive Plan on tobacco and nicotine that includes a clear acknowledgment of the FDA’s commitment to:
    1. the continuum of risk related to tobacco products and a recognition that ENDS and modern oral nicotine products sit at the lower end of the risk continuum,
    2. promoting innovation of those products at the lower end of the risk continuum, particularly ENDS and modern oral nicotine products,
    3. promoting innovation in nicotine, particularly synthetic nicotine,
    4. a pure scientific review process,
    5. funding science to evaluate the benefits of ENDS and modern oral nicotine products,
    6. working with companies to facilitate the application review process,
    7. aggressively educating adult smokers on the benefits of trying ENDS products if they are otherwise unwilling or unable to quit smoking using other methods,
    8. using its enforcement discretion to allow products under review to remain on the market pending authorization reviews, and
    9. a streamlined process which will ensure prompt review of product applications.
  2. CTP should engage industry and other stakeholders in the guidance and regulation processes by:
    1. Converting its listening sessions to engagement sessions so that CTP personnel are encouraged to communicate, ask questions and engage with stakeholders during meetings;
    2. Reinstituting its public stakeholder workshops which bring together all stakeholders to provide input on key regulatory policies and strategies; and
    3. Establishing an additional technical advisory committee dedicated to newly deemed alternative nicotine products to have a more focused strategy for less harmful nicotine products
  3. CTP should issue proposed regulation or guidance on product standards that:
    1. Explicitly allows widely accepted statistical design methods of research, aggregate testing, and extrapolation for ENDS product stability testing, and
    2. Permits manufacturers to market safety and/or quality enhancements with 60-Day notice to FDA.  

VTA Enforcement Recommendations

  1. CTP must use its full authority to ramp up interdiction of illicit products at the ports.
  2. CTP needs to streamline and reprioritize its enforcement efforts, rather than focusing so much on generally ineffective retail level enforcement.
  3. CTP should publish list of NTN products currently under PMTA review to facilitate industry and FDA enforcement efforts.
  4. CTP should restructure its enforcement efforts, through a guidance document, to achieve the following altered enforcement priorities:
    1. Stopping the flow all disposables into the U.S. market for which no PMTA has been filed by interdicting products at the ports;
    2. Enforcing against other ENDS products for which no PMTA has been filed, first prioritizing tobacco-derived products which make up the bulk of the market and then NTN products (since the latter are only a fraction of the market);
    3. Enforcing against counterfeit and illicit products which grossly violate marketing standards, trademark laws, or otherwise have marketing campaigns directed at youth; and
    4. Enforcing against products for which CTP has issued marketing denial orders (MDOs) after a full scientific review consistent with requirements of the Tobacco Control Act, except of course, those subject to an FDA administrative stay or a court-ordered stay of enforcement.

VTA Public Education & Communication Recommendations

  1. CTP must loudly and repeatedly correct the public record that nicotine does not cause cancer and that ENDS products, in the words of CTP Director King “have markedly less risk than a combustible cigarette”;
  2. CTP must commit equal resources to conducting an aggressive public education campaign, targeted to the adult consuming public, on the dangers of smoking and the lower risks of ENDS and modern oral nicotine products, explaining the continuum of risk, and encouraging adult smokers who have been unable or unwilling to quit to try e-cigarettes; and
  3. CTP must end the misleading youth education campaigns that are designed to scare youth (and adults) with false statements regarding the risks of e-cigarettes.
Read VTA’s Full Comments (PDF)

Filed Under: News, Reports

The VTA Submits Supreme Court Amicus Brief on Vaping Flavor Ban

November 16, 2022 by VTA Editors

WASHINGTON, November 15, 2022 (Newswire.com) – On Nov. 8, 2022, voters in California passed a ballot initiative (Proposition 31) upholding a 2020 law banning the sale of most flavored tobacco products. On Nov. 9, 2022, R.J. Reynolds (RJR), filed a federal lawsuit challenging California’s ban as being unlawfully preempted by the Family Smoking Prevention and Tobacco Control Act of 2009, (TCA). Yesterday, the Vapor Technology Association (VTA) filed an amicus brief with the Supreme Court of the United States in support of a Petition for Writ of Certiorari in another RJR case asserting similar arguments against the earlier L.A. County ordinance banning all flavored tobacco products. Supreme Court review is critical for two reasons.

First, the “substantial effect on the Nation’s economy” created by the sale of tobacco products is of great significance. The passage of the TCA in 2009 led to the creation of a new, independent distribution chain of companies, including manufacturers, distributors, suppliers, and retailers, that has steadily grown outside of the traditional tobacco products industry, offering their customers non-combustible nicotine vapor products as alternatives to smoking cigarettes. According to a new economic impact report (prepared by John Dunham & Associates), the independent vapor industry comprises more than 10,000 companies across the United States and is responsible for generating more than 130,000 jobs and more than $22 billion in economic activity for the U.S. economy.

This industry would be devastated by unrestricted flavor bans, given its unique and substantial reliance on the sale of flavored vapor products to adult consumers. Importantly, the potential shutdown of close to 10,000 businesses, causing the loss of 99,158 full-time equivalent (FTE) jobs, the loss of $5,258,906,715 in wages and benefits, and the loss of $16,449,776,269 to the U.S. economy makes the issue before the Court incredibly important. In the state of California, where the majority of e-liquid manufacturers of the independent vapor products industry are based, losses would total approximately 6,925 FTE jobs, paying $445,565,776 in wages and benefits, and the economic output of the California economy would be diminished by $1,497,332,882 if flavored vapor products could not be sold. 

Second, since the passage of the L.A. County Ordinance – leading tobacco-control scientists have challenged the notion of banning flavored e-cigarette flavors and have warned that decreasing availability of flavored vaping products harms the ability of adult smokers to quit smoking cigarettes. Instead of blanket bans, these tobacco-control scientists endorse alternative time, place and manner restrictions for the sale of flavored vaping products.

Permitting local and state governments to implement unscientific bans that directly interfere with the fundamental purpose of the TCA and would overrule the FDA’s decision-making for products deemed appropriate for the protection of public health, is not only unlawful, but is dangerous from a public health perspective, in VTA’s view.

ABOUT VTA
The Vapor Technology Association is the U.S. industry trade association whose members are dedicated to sound science-based regulation and selling innovative high-quality vapor products that provide adult smokers with a better alternative to combustible cigarettes. VTA represents the industry-leading manufacturers of vapor devices, e-liquids, and flavorings, as well as the distributors and retailers, including hardworking American mom-and-pop brick-and-mortar retail store owners.

Filed Under: News, Press Releases

  • 1
  • 2
  • Next Page »

Follow Us

  • Twitter
  • YouTube
  • Facebook

Copyright © 2026 Vapor Technology Association.
All Rights Reserved.

Privacy Policy |
Terms Of Use

Created by Black

Association

  • About VTA
  • Priorities
  • Governance
  • FAQ
  • News

Resources

  • Reports
  • Action Center
  • Economic Impact
  • Additional Resources

Action

  • Become A Member
  • Action Center
  • Subscribe to VTA Insider
  • American Impact
  • Contact

Let’s Connect

Loading

Subscribe to VTA

Loading

Myth vs Fact

Continue to VTA